Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans

Lena Brydon, Neil A Harrison, Cicely Walker, Andrew Steptoe, Hugo D Critchley, Lena Brydon, Neil A Harrison, Cicely Walker, Andrew Steptoe, Hugo D Critchley

Abstract

Background: Systemic infections commonly cause sickness symptoms including psychomotor retardation. Inflammatory cytokines released during the innate immune response are implicated in the communication of peripheral inflammatory signals to the brain.

Methods: We used functional magnetic resonance brain imaging (fMRI) to investigate neural effects of peripheral inflammation following typhoid vaccination in 16 healthy men, using a double-blind, randomized, crossover-controlled design.

Results: Vaccination had no global effect on neurovascular coupling but markedly perturbed neural reactivity within substantia nigra during low-level visual stimulation. During a cognitive task, individuals in whom typhoid vaccination engendered higher levels of circulating interleukin-6 had significantly slower reaction time responses. Prolonged reaction times and larger interleukin-6 responses were associated with evoked neural activity within substantia nigra.

Conclusions: Our findings provide mechanistic insights into the interaction between inflammation and neurocognitive performance, specifically implicating circulating cytokines and midbrain dopaminergic nuclei in mediating the psychomotor consequences of systemic infection.

Figures

Figure 1
Figure 1
High-contrast flashing checkerboard task used as a potent stimulus of primary visual cortical regions. Participants fixated on a cross at the center of the screen and pressed a key whenever the brightness of the cross changed.
Figure 2
Figure 2
Cognitive color-word Stroop task. Participants pressed a key to select the response word that correctly identified the print color of the target word. Congruent and incongruent conditions were presented separately and examples of these are illustrated here. In the congruent example (upper panel), the correct response is green. In the incongruent example, requiring greater cognitive effort (lower panel), the correct response is red.
Figure 3
Figure 3
Cytokine response to typhoid vaccination. A high-sensitivity, two-site ELISA was used to measure plasma concentrations of IL-6 in blood samples drawn at the beginning of each session (baseline) and 3 hours following intramuscular injection with either typhoid vaccine or normal saline placebo (postscan). Data are presented as the mean increase in picograms of IL-6 per milliliter of plasma ± SEM in vaccine (solid line) and placebo (dashed line) conditions (*p < .001, n = 16; significant treatment by sample interaction, F = 7.98, p = .013). ELISA, enzyme-linked immunosorbent assay; IL-6, interleukin-6.
Figure 4
Figure 4
Effect of peripheral inflammation on neural reactivity during low-grade visual stimulation task. (A) Mean BOLD signal change (+SEM) during checkerboard stimulus in all voxels probabilistically assigned to Brodmann areas 17 and 18 for vaccine and placebo conditions. There was no significant interaction between mean activation to visual stimulation and inflammatory state in either BA17 (p = .11) or BA18 (p = .34), confirming no effect of inflammation on neurovascular coupling. (B) Interaction between task performance and inflammatory state shows a highly significant change in BOLD signal within the left substantia nigra during performance of flashing checkerboard task (p = .002 after whole brain family-wise error [FWE] correction at p = .05). BA, Brodmann area; BOLD, blood oxygenation level-dependent; FWE, family-wise error.
Figure 5
Figure 5
Relationship between IL-6 response to typhoid vaccine and reaction time performance on Stroop task. Scatter plot illustrating the mean key press reaction time in milliseconds (congruent and incongruent conditions grouped) as a function of the mean plasma IL-6 response to typhoid vaccine (increase between baseline and 3 hours) (r = .82, p < .001). IL-6, interleukin-6.
Figure 6
Figure 6
IL-6 response to typhoid vaccine predicts enhanced neural activation within left substantia nigra during Stroop task performance. (A) fMRI analysis revealed heightened BOLD activity within left substantia nigra during performance of the cognitive Stroop task in the vaccine condition (threshold p < .001, illustrated at p < .005 uncorrected). (B) Scatter plot illustrating the relationship between substantia nigra activity (BOLD response within an 8 mm region of interest centered on the peak voxel at MNI −12, −2, −8) and mean IL-6 response to typhoid vaccine (p = .005). BOLD, blood oxygenation level-dependent; fMRI, functional magnetic resonance imaging; IL-6, interleukin-6; MNI, Montreal Neurological Institute.
Figure 7
Figure 7
Enhanced substantia nigra activity predicts reaction time slowing. Mean response time on the cognitive Stroop task was significantly correlated with neural activity in the same left substantia nigra region of interest. (A) Amplified image of BOLD response in left SN that covaried with reaction time in the vaccine condition. (B) Scatter plot illustrating the relationship between substantia nigra activity (BOLD response within an 8 mm region of interest centered on the peak voxel at MNI −12, −2, −8) and mean reaction time in typhoid vaccine condition (p = .03). BOLD, blood oxygenation level-dependent; MNI, Montreal Neurological Institute; SN, substantia nigra.

References

    1. Dantzer R., Bluthe R.M., Castanon N., Kelly K.W., Konsman J.-P., Laye S. Cytokines, sickness behavior, and depression. In: Ader R., editor. Psychoneuroimmunology. 4th ed. Elsevier; New York: 2007. pp. 281–318.
    1. Hart B.L. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12:123–137.
    1. Capuron L., Miller A.H. Cytokines and psychopathology: Lessons from interferon-alpha. Biol Psychiatry. 2004;56:819–824.
    1. Wright C.E., Strike P.C., Brydon L., Steptoe A. Acute inflammation and negative mood: Mediation by cytokine activation. Brain Behav Immun. 2005;19:345–350.
    1. Krabbe K.S., Reichenberg A., Yirmiya R., Smed A., Pedersen B.K., Bruunsgaard H. Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun. 2005;19:453–460.
    1. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry. 2001;58:445–452.
    1. Dunn A.J. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res. 2006;6:52–68.
    1. Hingorani A.D., Cross J., Kharbanda R.K., Mullen M.J., Bhagat K., Taylor M. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994–999.
    1. McNair D.M., Lorr N., Droppleman L.F. Education and Industrial Testing Service; San Diego: 1981. Manual for the Profile of Mood States.
    1. Deichmann R., Gottfried J.A., Hutton C., Turner R. Optimized EPI for fMRI studies of the orbitofrontal cortex. Neuroimage. 2003;19:430–441.
    1. Brydon L., Edwards S., Mohamed-Ali V., Steptoe A. Socioeconomic status and stress-induced increases in interleukin-6. Brain Behav Immun. 2004;18:281–290.
    1. Groenewegen H.J. The basal ganglia and motor control. Neural Plast. 2003;10:107–120.
    1. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci. 2004;5:483–494.
    1. Bunzeck N., Duzel E. Absolute coding of stimulus novelty in the human substantia nigra/VTA. Neuron. 2006;51:369–379.
    1. Horvitz J.C. Dopamine gating of glutamatergic sensorimotor and incentive motivational input signals to the striatum. Behav Brain Res. 2002;137:65–74.
    1. Baunez C., Robbins T.W. Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience. 1999;92:1343–1356.
    1. Weed M.R., Gold L.H. The effects of dopaminergic agents on reaction time in rhesus monkeys. Psychopharmacology (Berl) 1998;137:33–42.
    1. Capuron L., Pagnoni G., Demetrashvili M., Woolwine B.J., Nemeroff C.B., Berns G.S. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry. 2005;58:190–196.
    1. van Dyck C.H., Avery R.A., Macavoy M.G., Marek K.L., Quinlan D.M., Baldwin R.M. Striatal dopamine transporters correlate with simple reaction time in elderly subjects. Neurobiol Aging. 2007 Epub ahead of print: March 13, 2007.
    1. Wichmann T., DeLong M.R. Functional neuroanatomy of the basal ganglia in Parkinson's disease. Adv Neurol. 2003;91:9–18.
    1. Lenczowski M.J., Bluthe R.M., Roth J., Rees G.S., Rushforth D.A., van Dam A.M. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol. 1999;276:R652–R658.
    1. Pang Y., Fan L.W., Zheng B., Cai Z., Rhodes P.G. Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. Neuroscience. 2006;141:745–755.
    1. Harden L.M., du Plessis I., Poole S., Laburn H.P. Interleukin-6 and leptin mediate lipopolysaccharide-induced fever and sickness behavior. Physiol Behav. 2006;89:146–155.
    1. Bluthe R.M., Michaud B., Poli V., Dantzer R. Role of IL-6 in cytokine-induced sickness behavior: A study with IL-6 deficient mice. Physiol Behav. 2000;70:367–373.
    1. Shuto H., Kataoka Y., Horikawa T., Fujihara N., Oishi R. Repeated interferon-alpha administration inhibits dopaminergic neural activity in the mouse brain. Brain Res. 1997;747:348–351.
    1. Song C., Merali Z., Anisman H. Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience. 1999;88:823–836.
    1. Capuron L., Pagnoni G., Demetrashvili M.F., Lawson D.H., Fornwalt F.B., Woolwine B. Basal ganglia hypermetabolism and symptoms of fatigue during interferon-alpha therapy. Neuropsychopharmacology. 2007;32:2384–2392.
    1. Maes M., Bosmans E., De Jongh R., Kenis G., Vandoolaeghe E., Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1997;9:853–858.
    1. Martinot M., Bragulat V., Artiges E., Dolle F., Hinnen F., Jouvent R. Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation. Am J Psychiatry. 2001;158:314–316.
    1. Merali Z., Brennan K., Brau P., Anisman H. Dissociating anorexia and anhedonia elicited by interleukin-1beta: Antidepressant and gender effects on responding for “free chow” and “earned” sucrose intake. Psychopharmacology (Berl) 2003;165:413–418.
    1. Salamone J.D., Arizzi M.N., Sandoval M.D., Cervone K.M., Aberman J.E. Dopamine antagonists alter response allocation but do not suppress appetite for food in rats: Contrast between the effects of SKF 83566, raclopride, and fenfluramine on a concurrent choice task. Psychopharmacology (Berl) 2002;160:371–380.
    1. Abler B., Erk S., Walter H. Human reward system activation is modulated by a single dose of olanzapine in healthy subjects in an event-related, double-blind, placebo-controlled fMRI study. Psychopharmacology (Berl) 2007;191:823–833.
    1. Konsman J.P., Kelley K., Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. Neuroscience. 1999;89:535–548.
    1. Konsman J.P., Luheshi G.N., Bluthe R.M., Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals: A functional anatomical analysis. Eur J Neurosci. 2000;12:4434–4446.
    1. Dantzer R., Konsman J.P., Bluthe R.M., Kelley K.W. Neural and humoral pathways of communication from the immune system to the brain: Parallel or convergent? Auton Neurosci. 2000;85:60–65.
    1. Goehler L.E., Gaykema R.P., Hansen M.K., Anderson K., Maier S.F., Watkins L.R. Vagal immune-to-brain communication: A visceral chemosensory pathway. Auton Neurosci. 2000;85:49–59.
    1. Kim Y.S., Joh T.H. Microglia, major player in the brain inflammation: Their roles in the pathogenesis of Parkinson's disease. Exp Mol Med. 2006;38:333–347.
    1. Allan S.M., Rothwell N.J. Inflammation in central nervous system injury. Philos Trans R Soc Lond B Biol Sci. 2003;358:1669–1677.
    1. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007;7:161–167.
    1. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience. 2002;112:7–11.
    1. Kim W.G., Mohney R.P., Wilson B., Jeohn G.H., Liu B., Hong J.S. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: Role of microglia. J Neurosci. 2000;20:6309–6316.
    1. Gao H.M., Jiang J., Wilson B., Zhang W., Hong J.S., Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease. J Neurochem. 2002;81:1285–1297.
    1. Cicchetti F., Brownell A.L., Williams K., Chen Y.I., Livni E., Isacson O. Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging. Eur J Neurosci. 2002;15:991–998.
    1. Nagatsu T., Sawada M. Inflammatory process in Parkinson's disease: Role for cytokines. Curr Pharm Des. 2005;11:999–1016.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다